#504615
(Modh ina n-úsáidtear démheitiolformaimíd)
(Method using dimethylformamide)
Scag na torthaí
Bailiúcháin
27 toradh in 10 ndoiciméad
#504623
Démheitiolformaimíd (fiuchphointe 153 ± 1 °C) nach mó ná 0,1 % uisce atá ann.
Dimethylformamide (boiling point 153 ± 1 °C) not containing more than 0,1 % water.
#504630
Aistrigh aon snáithín iarmharach isteach sa bhreogán tríd an eascra a ní le démheitiolformaimíd.
Transfer any residual fibre to the crucible by washing out the beaker with dimethylformamide.
#1934397
N, N-Démheitiolformaimíd
N, N-Dimethylformamide
#1934398
N, N-Démheitiolformaimíd; Formaimíd démheitile, DNF
N, N-dimethylformamide; Dimethyl formamide, DMF
#2158008
N,N-démheitiolformaimíd
N,N-dimethylformamide
#2184508
nó N,N-démheitiolformaimíd,
or N,N-dimethylformamide,
#2268544
N,N Démheitiolformaimíd
N,N Dimethylformamide
#2437358
Démheitiolformaimíd
Dimethylformamide
#2608504
nó N,N-démheitiolformaimíd,
or N,N-dimethylformamide,
#3146551
nó N,N-démheitiolformaimíd,
or N,N-dimethylformamide,
#3233959
N, N-démheitiolformaimíd (DMF).
N, N-dimethylformamide (DMF).
#2157986
Agus sainchomhad Iarscríbhinn XV agus tuairimí RAC agus SEAC á gcur san áireamh aige, measann an Coimisiún go bhfuil riosca do-ghlactha ann d’oibrithe de bharr a dteagmhála le N,N —démheitiolformaimíd os cionn luachanna sonracha DNEL, agus gurb é an srian a moladh lena mbunaítear DNEL maidir le teagmháil oibrithe le N,N —démheitiolformaimíd trí bhealach an ionanálaithe agus bealach an chraicinn, gurb é sin an beart uile-Aontais is iomchuí chun aghaidh a thabhairt ar an riosca sin.
Taking into account the Annex XV dossier and the RAC and SEAC opinions, the Commission considers that there is an unacceptable risk to workers arising from exposure to N,N–dimethylformamide above specific DNEL values and that the proposed restriction establishing a DNEL for exposure of workers to N,N–dimethylformamide via both the inhalation and the dermal routes is the most appropriate Union-wide measure to address that risk.
#2157991
Dá bhrí sin, moltar idirthréimhsí níos faide le haghaidh earnáil na mbratuithe agus na scannán polúireatáin, earnáil ina n-úsáidtear N,N –démheitiolformaimíd mar thuaslagóir i bpróisis dhíreacha agus próisis aistrithe um bratú polúireatáin ar theicstílí agus ar ábhar páipéir nó i dtáirgeadh scannán polúireatáin (36 mhí), agus le haghaidh na hearnála monaraíochta snáithíní sintéiseacha, earnáil ina n-úsáidtear N,N –démheitiolformaimíd mar thuaslagóir sna próisis thirime agus fhliucha um shníomhachán snáithíní sintéiseacha (48 mí).
Therefore, longer transitional periods are suggested for the polyurethane coatings and membranes sector, where N,N–dimethylformamide is used as a solvent in direct or transfer polyurethane coating processes on textiles and paper material or in the production of polyurethane membranes (36 months) and, for the synthetic fibre manufacturing, where N,N–dimethylformamide is used as a solvent in the dry and wet spinning processes of synthetic fibres (48 months).
#2158013
De mhaolú ar mhíreanna 1 agus 2, beidh feidhm ag na hoibleagáidí a leagtar síos iontu ón 12 Nollaig 2024 i ndáil le N,N-démheitiolformaimíd a úsáid, nó a chur ar an margadh lena húsáid, mar thuaslagóir i bpróisis dhíreacha nó próisis aistrithe chun teicstílí agus ábhar páipéir a bhratú faoi pholúireatán nó i dtáirgeadh scannán polúireatáin, agus ón 12 Nollaig 2025 i ndáil le N,N-démheitiolformaimíd a úsáid, nó a chur ar an margadh lena húsáid, mar thuaslagóir sna próisis thirime agus fhliucha um shníomhachán snáithíní sintéiseacha.”
By way of derogation from paragraphs 1 and 2, the obligations laid down therein shall apply from 12 December 2024 in relation to placing on the market for use, or use, as a solvent in direct or transfer polyurethane coating processes of textiles and paper material or the production of polyurethane membranes, and from 12 December 2025 in relation to placing on the market for use, or use, as a solvent in the dry and wet spinning processes of synthetic fibres.’
#504619
Déantar an t-aicrileach, an modaicrileach nó an clórashnáithín a thuaslagadh as mais thirim aithnid den mheascán le démheitiolformaimíd atá téite i ndabhach uisce atá ag an bhfiuchphointe.
The acrylic, modacrylic or chlorofibre is dissolved out from a known dry mass of the mixture, with dimethylformamide heated in a water-bath at boiling point.
#2157970
Substaint d’ardtoirt táirgeachta atá in N,N —démheitiolformaimíd, agus is iomaí suíomh tionsclaíoch agus gníomhaíocht ghairmiúl ina mbaintear úsáid aisti ar fud na hEorpa.
N,N–dimethylformamide is a high production volume substance used in many industrial settings and professional activities across Europe.
#2157963
lena leasaítear Iarscríbhinn XVII a ghabhann le Rialachán (CE) Uimh. 1907/2006 ó Pharlaimint na hEorpa agus ón gComhairle maidir le Clárú, Meastóireacht, Údarú agus Srianadh Ceimiceán (REACH) a mhéid a bhaineann le N,N-démheitiolformaimíd
amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards N,N-dimethylformamide
#2157969
Tuaslagóir orgánach aprúach meánpholach atá in N,N —démheitiolformaimíd atá aicmithe mar thocsain i leith atáirgeadh de chineál 1B, tocsain ghéar de chineál 4 (trí bhealach an ionanálaithe agus bealach an chraicinn), agus greannach súl de chineál 2 i gcomhréir le Rialachán (CE) Uimh. 1272/2008 ó Pharlaimint na hEorpa agus ón gComhairle.
N,N–dimethylformamide is an aprotic medium polar organic solvent classified as toxic to reproduction 1B, acute toxicant 4 (inhalation and dermal route) and as an eye irritant 2 in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council.
#2157975
An 20 Meán Fómhair 2019, ghlac Coiste um Measúnú Riosca na Gníomhaireachta (“RAC”) tuairim lenar chinn sé gurb é an srian a moladh, faoi mar a bhí sé modhnaithe ag RAC, gurb é sin an beart uile-Aontais ab iomchuí chun aghaidh a thabhairt ar na rioscaí a sainaithníodh atá ann de bharr teagmháil le N,N —démheitiolformaimíd, is é sin gurb é an beart ab iomchuí é i dtéarmaí praiticiúlachta, inmhonatóireachta, agus éifeachtacht i laghdú an riosca.
On 20 September 2019, the Agency’s Committee for Risk Assessment (‘RAC’) adopted its opinion concluding that the proposed restriction, as modified by RAC, is the most appropriate Union-wide measure to address the identified risks arising from exposure to N,N–dimethylformamide in terms of its effectiveness in reducing the risk, its practicality and monitorability.
#2157976
Maidir le substaintí ina bhfuil tiúchan íseal N,N —démheitiolformaimíde, breithníodh roinnt cásanna rannchuiditheacha sa mheastóireacht a rinne aighnitheoir an tsainchomhaid, agus ar an ábhar sin, mhol RAC foclaíocht an raoin feidhme a shoiléiriú trína chuimsiú ann N,N —démheitiolformaimíd a bheith i láthair cibé acu is comhábhar, príomh-chomhábhar, eisíontas nó cobhsaitheoir atá inti.
As the dossier submitter’s assessment considered several contributing scenarios for N,N–dimethylformamide containing substances at low concentrations, RAC proposed to clarify the wording of the scope by including the presence of the substance, regardless of whether N,N–dimethylformamide is a constituent, a main constituent, an impurity or a stabiliser.
#2157981
An 5 Nollaig 2019, ghlac Coiste um Anailís Shocheacnamaíoch (“SEAC”) na Gníomhaireachta tuairim lenar chinn sé gurb é an srian a moladh, faoi mar a bhí sé modhnaithe ag RAC, gurb é sin an beart uile-Aontais ab iomchuí chun an riosca atá ann do shláinte oibrithe de bharr N,N —démheitiolformaimíd a laghdú, rud a cinneadh agus costais agus tairbhí socheacnamaíocha an bhirt sin á gcur san áireamh.
On 5 December 2019, the Agency’s Committee for Socio-Economic Analysis (‘SEAC’) adopted its opinion, concluding that the proposed restriction, as modified by RAC, is the most appropriate Union-wide measure to reduce the risk to the health of workers arising from N,N–dimethylformamide, taking into account its socioeconomic benefits and costs.
#2157987
An srian atá molta, faoi mar atá sé modhnaithe ag RAC agus SEAC, measann an Coimisiún go bhfuil sé iomchuí ar na cúiseanna seo a leanas: an cóimheas foriomlán tréithrithe riosca, is ar DNELanna cainníochtaithe maidir le teagmháil le N,N —démheitiolformaimíd trí bhealach an ionanálaithe agus bealach an chraicinn atá sé bunaithe; is faoi Rialachán (CE) Uimh. 1907/2006 amháin is féidir tuarascálacha maidir le sábháilteacht cheimiceach sna sainchomhaid chlárúcháin a chomhchuibhiú trí DNELanna comhchuibhithe; cuimseofar na DNELanna sin sna ranna sonracha iomchuí de na bileoga sonraí sábháilteachta.
The Commission considers that the proposed restriction, as modified by RAC and SEAC, is appropriate for the following reasons: the overall risk characterisation ratio is based on quantified DNELs for inhalation and dermal exposure to N,N–dimethylformamide; harmonisation of chemical safety reports in the registration dossiers via harmonised DNELs can only be achieved under Regulation (EC) No 1907/2006; the safety data sheets will include those DNELs in the appropriate specific sections.
#2157988
Ba cheart a ndóthain ama a thabhairt do pháirtithe leasmhara chun an srian atá molta a chomhlíonadh, agus i gcás úsáideoirí iartheachtacha go háirithe, ba cheart an tréimhse chéanna a bheith acusan agus a bheidh ag monaróirí agus allmhaireoirí chun na bearta bainistithe riosca agus na coinníollacha oibríochtúla is iomchuí a chur chun feidhme ar mhaithe lena áirithiú go mbeidh teagmháil oibrithe le N,N —démheitiolformaimíd faoi bhun na DNELanna.
Stakeholders should be allowed sufficient time to comply with the proposed restriction, and downstream users, in particular, should have the same time period as manufacturers and importers to implement the appropriate risk management measures and operational conditions in order to ensure that exposure of workers to N,N–dimethylformamide is below the DNELs.
#2157990
Chun na DNELanna i ndáil le teagmháil oibrithe le N,N–démheitiolformaimíd a chomhlíonadh, earnáil na mbratuithe agus na scannán polúireatáin agus an earnáil monaraíochta snáithíní sintéiseacha, táthar ag súil go mbeidh tuilleadh ama ag teastáil ó na hearnálacha sin.
It is expected that, to comply with the DNELs for exposure of workers to N,N–dimethylformamide, the polyurethane coatings and membranes and the synthetic fibre manufacturing sectors will require more time.
#2158011
Ní chuirfear ar an margadh í mar shubstaint léi féin, mar chomhábhar de chuid substaintí eile, ná i meascáin i dtiúchan is cothrom le 0,3 % nó is ísle ná sin ón 12 Nollaig 2023 mura rud é go ndearna monaróirí, allmhaireoirí agus úsáideoirí iartheachtacha na leibhéil neamhéifeachta díorthaithe (DNELanna) seo a leanas i ndáil le teagmháil oibrithe, na leibhéil seo a chuimsiú sna tuarascálacha maidir le sábháilteacht cheimiceach agus sna bileoga sonraí sábháilteachta lena mbaineann – 6 mg/m3 i gcás N,N-démheitiolformaimíd a thógáil d’ionanálú, agus 1,1 mg/kg/lá i gcás í a thógáil tríd an gcraiceann.
Shall not be placed on the market as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0,3 % after 12 December 2023 unless manufacturers, importers and downstream users have included in the relevant chemical safety reports and safety data sheets, Derived No-Effect Levels (DNELs) relating to exposure of workers of 6 mg/m3 for exposure by inhalation and 1,1 mg/kg/day for dermal exposure.
#2659703
Rialachán (AE) 2021/2030 ón gCoimisiún an 19 Samhain 2021 lena leasaítear Iarscríbhinn XVII a ghabhann le Rialachán (CE) Uimh. 1907/2006 ó Pharlaimint na hEorpa agus ón gComhairle maidir le Clárú, Meastóireacht, Údarú agus Srianadh Ceimiceán (REACH) a mhéid a bhaineann le N,N-démheitiolformaimíd, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2021/2030 of 19 November 2021 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards N,N-dimethylformamide is to be incorporated into the EEA Agreement.